...
首页> 外文期刊>Psychosomatics >Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
【24h】

Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?

机译:纤维肌痛是内分泌/内啡肽缺乏症吗?低剂量纳曲酮是否是新的治疗选择?

获取原文
获取原文并翻译 | 示例
           

摘要

Fibromyalgia is a chronic pain syndrome. Neuman and Buskila1 noted that fibromyalgia afflicts approximately 5% of women and 1.6% of men. The diagnosis of fibromyalgia "is primarily based on- chronic widespread pain that has (1) pain on both sides of the body, (2) is above and below the waist, (3) should involve the axial skeleton, and (4) must have been present for more than 3 months. Physical examination must include at least 11 of 18 tender points.2 In clinical practice, nearly half the population^ may have fewer tender points. A new proposed fibromyalgia syndrome also includes sleep deficits, daytime fatigue, and altered cognition/mood as a part of the syndrome.3 Comorbid psychiatric disorders are common in fibromyalgia. Arnold et al.4 reported that 75% of patients with fibromyalgia have a mood disorder, 60% have an anxiety disorder, and 26% have a substance use disorder.
机译:纤维肌痛是一种慢性疼痛综合征。 Neuman和Buskila1指出,纤维肌痛困扰着大约5%的女性和1.6%的男性。纤维肌痛的诊断主要基于慢性广泛性疼痛,该疼痛具有(1)身体两侧疼痛,(2)腰部以上和以下,(3)涉及轴向骨骼,以及(4)必须已经存在超过3个月了。体格检查必须包括18个压痛点中的至少11个。2在临床实践中,将近一半的人口^可能有较少的压痛点。 3并发性精神病在纤维肌痛中很常见,Arnold等人[4]报告说,75%的纤维肌痛患者有情绪障碍,60%的患者患有焦虑症,26%的患者患有情绪障碍。物质使用障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号